{
    "Trade/Device Name(s)": [
        "Triglycerides (TRIGS)"
    ],
    "Submitter Information": "Randox Laboratories Limited",
    "510(k) Number": "K150819",
    "Predicate Device Reference 510(k) Number(s)": [
        "K923508"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CDT"
    ],
    "Summary Letter Date": "June 18, 2015",
    "Summary Letter Received Date": "June 22, 2015",
    "Submission Date": "July 9, 2015",
    "Regulation Number(s)": [
        "21CFR862.1705"
    ],
    "Regulation Name(s)": [
        "Triglyceride test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Triglycerides"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX Daytona Plus"
    ],
    "Method(s)/Technology(ies)": [
        "Colorimetric method",
        "Enzymatic hydrolysis and oxidation"
    ],
    "Methodologies": [
        "Clinical chemistry assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Triglycerides (TRIGS) colorimetric assay for quantitative determination of triglycerides in serum using the RX Daytona Plus analyzer.",
    "Indications for Use Summary": "For quantitative in vitro determination of triglycerides in serum; used in diagnosis and treatment of diseases involving lipid metabolism and various endocrine disorders such as diabetes mellitus, nephrosis, and liver obstruction.",
    "fda_folder": "Clinical Chemistry"
}